In rare disease care, communication between patients and physicians is often fragmented, leading to misalignment in understanding, expectations, and outcomes.
But as explored in KJT’s recent two-part webinar series, the reality is more complex.
The “gap” is not just about what is said in the exam room. It reflects a broader set of challenges across diagnosis, treatment, and ongoing care, shaped by time constraints, system limitations, emotional burden, and misaligned expectations.
Understanding this gap requires looking at both perspectives together.
The Patient Experience: Navigating Uncertainty Without a Clear Path
For many rare disease patients, the journey is long, fragmented, and emotionally taxing.
Symptoms are often misunderstood or dismissed. Diagnoses can take years. Along the way, patients are frequently required to repeat their story across multiple providers, without clear progress or continuity.
In some cases, patients report being told their symptoms are psychological or exaggerated, even when their condition is actively worsening. These experiences do more than delay diagnosis. They erode trust.
Over time, patients are not only managing their condition but also navigating uncertainty, advocating for themselves, and trying to make sense of conflicting information.
The Physician Perspective: Balancing Complexity Under Constraint
Physicians approach rare disease care with a different set of pressures.
Appointments are limited. Clinical priorities must be addressed quickly. And the focus is often on stabilizing disease progression and selecting appropriate treatments.
At the same time, rare diseases are inherently complex. Explaining them clearly, aligning on expectations, and ensuring patient understanding within a short visit is not always straightforward.
Even with the best intent, physicians and patients can leave the same conversation with different interpretations of what was discussed and what matters most.
Where the Gap Emerges
The communication gap in rare disease care is rarely caused by one side alone.
It emerges at the intersection of multiple factors:
- Diagnostic uncertainty and delayed specialist access
- Fragmented care across providers and settings
- Differences in how patients and physicians define success
- Limited time to explain, reinforce, and confirm understanding
- The emotional toll carried by patients throughout their journey
These dynamics often surface at critical moments, including initial diagnosis, treatment discussions, and ongoing management.
In these moments, what is said, what is heard, and what is understood are not always aligned.
What Better Communication Looks Like
Improving communication in rare disease care does not require more information. It requires more intentional alignment.
This includes:
- Establishing a clear and shared understanding of the condition early
- Using language that is accessible and tailored to the patient
- Prioritizing the patient’s most immediate concerns alongside clinical goals
- Creating space to confirm understanding, not just deliver information
- Building consistency across visits and care touchpoints
When communication is structured in this way, it becomes easier to bridge the gap between clinical intent and patient experience.
The Role of Research in Closing the Gap
Traditional research often captures patient and physician perspectives separately.
While valuable, this approach can miss the real breakdown: in the interaction itself.
To truly improve communication, research must examine both perspectives together, identifying where understanding diverges and how those gaps can be addressed.
By observing how conversations unfold in real time, followed by separate follow-up conversations, it becomes possible not only to see where the breakdown occurred but to design more effective communication strategies, patient support tools, and educational resources that reflect real-world needs.
Why This Matters for Pharma and Med Affairs
For pharma, medical affairs, and evidence teams, these insights have direct implications.
Bridging the communication gap can lead to:
- More effective patient support materials
- Stronger alignment in treatment discussions
- Improved HCP communication tools
- More patient-centered research design
- Greater confidence that messaging reflects lived experience
In complex and evolving disease areas, clarity and alignment are not optional. They are essential to delivering meaningful outcomes.
Closing Thought
In rare disease care, better communication is not simply about saying more.
It is about ensuring that what is said is understood, trusted, and aligned with the realities patients face every day.
Bridging the gap starts by looking beyond individual perspectives and focusing on the space between them, where understanding is either built or lost.
Author
Danny Wolin
SVP, Real World Evidence
Danny Wolin has over 25 years of RWE and regulatory affairs experience in the pharmaceutical industry. He has a proven track record of collaborative partnership in the design and leadership of qualitative and quantitative RWE studies across multiple therapeutic areas that help inform important healthcare decisions.
